Search research articles
Contact Us
Filters
Showing results (141-150 of 481) with videos related to
Page
of 49
Sort By:
Cancer Research
|
February 15, 1996
Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents
D S Hawkins, G W Demers, D A Galloway
Journal of Pharmaceutical Sciences
|
May 1, 1977
GLC determination of acetohexamide and hydroxyhexamide in biological fluids
J W Kleber, J A Galloway, B E Rodda
Journal of Studies on Alcohol
|
July 29, 2005
Coping motives as a moderator of daily mood-drinking covariation
Andrea M Hussong, Christopher A Galloway, Laura A Feagans
Acta Endocrinologica. Supplementum
|
January 1, 1976
The immunogenicity of insulin preparations
R E Chance, M A Root, J A Galloway
Journal of Virology
|
January 1, 1991
The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells
C L Halbert, G W Demers, D A Galloway
Virology
|
January 1, 1987
Characterization of the integration site of the CMV mtr in a tumor cell line
F M Buonaguro, J K McDougall, D A Galloway
Journal of Virology
|
September 20, 2002
Inactivation of both the retinoblastoma tumor suppressor and p21 by the human papillomavirus type 16 E7 oncoprotein is necessary to inhibit cell cycle arrest in human epithelial cells
Anna-Marija Helt, Jens Oliver Funk, Denise A Galloway
Biotechniques
|
March 29, 2003
Increasing the yield of soluble recombinant protein expressed in E. coli by induction during late log phase
Chad A Galloway, Mark P Sowden, Harold C Smith
Plos One
|
June 26, 2009
c-Myc accelerates S-phase and requires WRN to avoid replication stress
Kristin Robinson, Nichaya Asawachaicharn, Denise A Galloway, et al.
The Journal of Infectious Diseases
|
September 1, 1993
Sequence and antigenic diversity in two immunodominant regions of the L2 protein of human papillomavirus types 6 and 16
N Yaegashi, L Xi, M Batra, et al.
Page
of 49
Search research articles
Search
Showing results (141-150 of 481) with videos related to
Sort By:
Page
of 49
Cancer Research
|
February 15, 1996
Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents
D S Hawkins, G W Demers, D A Galloway
Journal of Pharmaceutical Sciences
|
May 1, 1977
GLC determination of acetohexamide and hydroxyhexamide in biological fluids
J W Kleber, J A Galloway, B E Rodda
Journal of Studies on Alcohol
|
July 29, 2005
Coping motives as a moderator of daily mood-drinking covariation
Andrea M Hussong, Christopher A Galloway, Laura A Feagans
Acta Endocrinologica. Supplementum
|
January 1, 1976
The immunogenicity of insulin preparations
R E Chance, M A Root, J A Galloway
Journal of Virology
|
January 1, 1991
The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells
C L Halbert, G W Demers, D A Galloway
Virology
|
January 1, 1987
Characterization of the integration site of the CMV mtr in a tumor cell line
F M Buonaguro, J K McDougall, D A Galloway
Journal of Virology
|
September 20, 2002
Inactivation of both the retinoblastoma tumor suppressor and p21 by the human papillomavirus type 16 E7 oncoprotein is necessary to inhibit cell cycle arrest in human epithelial cells
Anna-Marija Helt, Jens Oliver Funk, Denise A Galloway
Biotechniques
|
March 29, 2003
Increasing the yield of soluble recombinant protein expressed in E. coli by induction during late log phase
Chad A Galloway, Mark P Sowden, Harold C Smith
Plos One
|
June 26, 2009
c-Myc accelerates S-phase and requires WRN to avoid replication stress
Kristin Robinson, Nichaya Asawachaicharn, Denise A Galloway, et al.
The Journal of Infectious Diseases
|
September 1, 1993
Sequence and antigenic diversity in two immunodominant regions of the L2 protein of human papillomavirus types 6 and 16
N Yaegashi, L Xi, M Batra, et al.
Page
of 49